カテゴリー： 世界, 医療/バイオ, LP Information

世界の抗けいれん薬市場予測 2023年-2029年

【英語タイトル】Global Anticonvulsant Drug Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02887）・商品コード：LP23DC02887
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の抗けいれん薬市場」は、過去の販売実績から2022年の世界の抗けいれん薬の総販売量を検討し、2023年から2029年の予測される抗けいれん薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗けいれん薬の市場規模を掲載し、XXX百万米ドル規模の世界の抗けいれん薬市場の詳細な分析を提供します。本インサイトレポートは、世界の抗けいれん薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の抗けいれん薬市場における各社の独自のポジションをより深く理解するために、抗けいれん薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の抗けいれん薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗けいれん薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。抗けいれん薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗けいれん薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

抗けいれん薬の世界主要メーカーとしては、GlaxoSmithKline Plc、 Astellas Pharma Technologies、 Valeant Pharmaceuticals N.A、 Bausch Health Companies、 Watson Laboratories、 Abbott Laboratories、 Teva Pharmaceutical Industries、 Johnson & Johnson、 Novartis AG、 Pfizer、 Shire Plc、 UCB Group、 Huazhong Pharmaceutical Company Limited、 Changzhou Siyao Pharmaceutical、 Shandong Xinyi Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の抗けいれん薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では抗けいれん薬市場をセグメンテーションし、種類別 (α-アミノ-3-ヒドロキシ-5-メチル-4-イソオキサゾールプロピオン酸（AMPA）、バルビツール酸系、ベンゾジアゼピン系、カーバメート系抗けいれん薬、炭酸脱水酵素阻害薬、ジベンザゼピン系、トリアジン系)、用途別 (不安障害、双極性障害、境界性人格障害、てんかん、線維筋痛症、片頭痛、神経障害性疼痛、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：α-アミノ-3-ヒドロキシ-5-メチル-4-イソオキサゾールプロピオン酸（AMPA）、バルビツール酸系、ベンゾジアゼピン系、カーバメート系抗けいれん薬、炭酸脱水酵素阻害薬、ジベンザゼピン系、トリアジン系

・用途別区分：不安障害、双極性障害、境界性人格障害、てんかん、線維筋痛症、片頭痛、神経障害性疼痛、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の抗けいれん薬市場の10年間の市場状況・展望は？
・世界および地域別に見た抗けいれん薬市場成長の要因は何か？
・抗けいれん薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・抗けいれん薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：抗けいれん薬の年間販売量2018-2029、地域別現状・将来分析
・抗けいれん薬の種類別セグメント：α-アミノ-3-ヒドロキシ-5-メチル-4-イソオキサゾールプロピオン酸（AMPA）、バルビツール酸系、ベンゾジアゼピン系、カーバメート系抗けいれん薬、炭酸脱水酵素阻害薬、ジベンザゼピン系、トリアジン系
・抗けいれん薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・抗けいれん薬の用途別セグメント：不安障害、双極性障害、境界性人格障害、てんかん、線維筋痛症、片頭痛、神経障害性疼痛、その他
・抗けいれん薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の抗けいれん薬市場
・企業別のグローバル抗けいれん薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の抗けいれん薬の年間売上：2018-2023年の売上、市場シェア
・企業別の抗けいれん薬販売価格
・主要企業の抗けいれん薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

抗けいれん薬の地域別レビュー
・地域別の抗けいれん薬市場規模2018-2023：年間販売量、売上
・主要国別の抗けいれん薬市場規模2018-2023：年間販売量、売上
・南北アメリカの抗けいれん薬販売の成長
・アジア太平洋の抗けいれん薬販売の成長
・ヨーロッパの抗けいれん薬販売の成長
・中東・アフリカの抗けいれん薬販売の成長

南北アメリカ市場
・南北アメリカの国別の抗けいれん薬販売量、売上（2018-2023）
・南北アメリカの抗けいれん薬の種類別販売量
・南北アメリカの抗けいれん薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の抗けいれん薬販売量、売上（2018-2023）
・アジア太平洋の抗けいれん薬の種類別販売量
・アジア太平洋の抗けいれん薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の抗けいれん薬販売量、売上（2018-2023）
・ヨーロッパの抗けいれん薬の種類別販売量
・ヨーロッパの抗けいれん薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の抗けいれん薬販売量、売上（2018-2023）
・中東・アフリカの抗けいれん薬の種類別販売量
・中東・アフリカの抗けいれん薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・抗けいれん薬の製造コスト構造分析
・抗けいれん薬の製造プロセス分析
・抗けいれん薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・抗けいれん薬の主要なグローバル販売業者
・抗けいれん薬の主要なグローバル顧客

地域別の抗けいれん薬市場予測レビュー
・地域別の抗けいれん薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・抗けいれん薬の種類別市場規模予測
・抗けいれん薬の用途別市場規模予測

主要企業分析
GlaxoSmithKline Plc、 Astellas Pharma Technologies、 Valeant Pharmaceuticals N.A、 Bausch Health Companies、 Watson Laboratories、 Abbott Laboratories、 Teva Pharmaceutical Industries、 Johnson & Johnson、 Novartis AG、 Pfizer、 Shire Plc、 UCB Group、 Huazhong Pharmaceutical Company Limited、 Changzhou Siyao Pharmaceutical、 Shandong Xinyi Pharmaceutical
・企業情報
・抗けいれん薬製品
・抗けいれん薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Anticonvulsant Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anticonvulsant Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anticonvulsant Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anticonvulsant Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anticonvulsant Drug players cover GlaxoSmithKline Plc, Astellas Pharma Technologies, Valeant Pharmaceuticals N.A, Bausch Health Companies, Watson Laboratories, Abbott Laboratories, Teva Pharmaceutical Industries, Johnson & Johnson and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The anticonvulsant drug is a type of drug that is used to prevent or treat seizures or convulsions by controlling abnormal electrical activity in the brain.
LPI (LP Information)’ newest research report, the “Anticonvulsant Drug Industry Forecast” looks at past sales and reviews total world Anticonvulsant Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Anticonvulsant Drug sales for 2023 through 2029. With Anticonvulsant Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticonvulsant Drug industry.
This Insight Report provides a comprehensive analysis of the global Anticonvulsant Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anticonvulsant Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticonvulsant Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticonvulsant Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticonvulsant Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticonvulsant Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
Barbiturate
Benzodiazepine
Carbamate Anticonvulsants
Carbonic Anhydrase Inhibitor
Dibenzazepine
Triazine
Segmentation by application
Anxiety
Bipolar Disorder
Borderline Personality Disorder
Epilepsy
Fibromyalgia
Migraine
Neuropathic Pain
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
GlaxoSmithKline Plc
Astellas Pharma Technologies
Valeant Pharmaceuticals N.A
Bausch Health Companies
Watson Laboratories
Abbott Laboratories
Teva Pharmaceutical Industries
Johnson & Johnson
Novartis AG
Pfizer
Shire Plc
UCB Group
Huazhong Pharmaceutical Company Limited
Changzhou Siyao Pharmaceutical
Shandong Xinyi Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anticonvulsant Drug market?
What factors are driving Anticonvulsant Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anticonvulsant Drug market opportunities vary by end market size?
How does Anticonvulsant Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticonvulsant Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anticonvulsant Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anticonvulsant Drug by Country/Region, 2018, 2022 & 2029
2.2 Anticonvulsant Drug Segment by Type
2.2.1 α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
2.2.2 Barbiturate
2.2.3 Benzodiazepine
2.2.4 Carbamate Anticonvulsants
2.2.5 Carbonic Anhydrase Inhibitor
2.2.6 Dibenzazepine
2.2.7 Triazine
2.3 Anticonvulsant Drug Sales by Type
2.3.1 Global Anticonvulsant Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Anticonvulsant Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anticonvulsant Drug Sale Price by Type (2018-2023)
2.4 Anticonvulsant Drug Segment by Application
2.4.1 Anxiety
2.4.2 Bipolar Disorder
2.4.3 Borderline Personality Disorder
2.4.4 Epilepsy
2.4.5 Fibromyalgia
2.4.6 Migraine
2.4.7 Neuropathic Pain
2.4.8 Others
2.5 Anticonvulsant Drug Sales by Application
2.5.1 Global Anticonvulsant Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Anticonvulsant Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anticonvulsant Drug Sale Price by Application (2018-2023)
3 Global Anticonvulsant Drug by Company
3.1 Global Anticonvulsant Drug Breakdown Data by Company
3.1.1 Global Anticonvulsant Drug Annual Sales by Company (2018-2023)
3.1.2 Global Anticonvulsant Drug Sales Market Share by Company (2018-2023)
3.2 Global Anticonvulsant Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Anticonvulsant Drug Revenue by Company (2018-2023)
3.2.2 Global Anticonvulsant Drug Revenue Market Share by Company (2018-2023)
3.3 Global Anticonvulsant Drug Sale Price by Company
3.4 Key Manufacturers Anticonvulsant Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anticonvulsant Drug Product Location Distribution
3.4.2 Players Anticonvulsant Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anticonvulsant Drug by Geographic Region
4.1 World Historic Anticonvulsant Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Anticonvulsant Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anticonvulsant Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anticonvulsant Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Anticonvulsant Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anticonvulsant Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anticonvulsant Drug Sales Growth
4.4 APAC Anticonvulsant Drug Sales Growth
4.5 Europe Anticonvulsant Drug Sales Growth
4.6 Middle East & Africa Anticonvulsant Drug Sales Growth
5 Americas
5.1 Americas Anticonvulsant Drug Sales by Country
5.1.1 Americas Anticonvulsant Drug Sales by Country (2018-2023)
5.1.2 Americas Anticonvulsant Drug Revenue by Country (2018-2023)
5.2 Americas Anticonvulsant Drug Sales by Type
5.3 Americas Anticonvulsant Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticonvulsant Drug Sales by Region
6.1.1 APAC Anticonvulsant Drug Sales by Region (2018-2023)
6.1.2 APAC Anticonvulsant Drug Revenue by Region (2018-2023)
6.2 APAC Anticonvulsant Drug Sales by Type
6.3 APAC Anticonvulsant Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anticonvulsant Drug by Country
7.1.1 Europe Anticonvulsant Drug Sales by Country (2018-2023)
7.1.2 Europe Anticonvulsant Drug Revenue by Country (2018-2023)
7.2 Europe Anticonvulsant Drug Sales by Type
7.3 Europe Anticonvulsant Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anticonvulsant Drug by Country
8.1.1 Middle East & Africa Anticonvulsant Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anticonvulsant Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Anticonvulsant Drug Sales by Type
8.3 Middle East & Africa Anticonvulsant Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anticonvulsant Drug
10.3 Manufacturing Process Analysis of Anticonvulsant Drug
10.4 Industry Chain Structure of Anticonvulsant Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anticonvulsant Drug Distributors
11.3 Anticonvulsant Drug Customer
12 World Forecast Review for Anticonvulsant Drug by Geographic Region
12.1 Global Anticonvulsant Drug Market Size Forecast by Region
12.1.1 Global Anticonvulsant Drug Forecast by Region (2024-2029)
12.1.2 Global Anticonvulsant Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anticonvulsant Drug Forecast by Type
12.7 Global Anticonvulsant Drug Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc Company Information
13.1.2 GlaxoSmithKline Plc Anticonvulsant Drug Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Plc Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Plc Main Business Overview
13.1.5 GlaxoSmithKline Plc Latest Developments
13.2 Astellas Pharma Technologies
13.2.1 Astellas Pharma Technologies Company Information
13.2.2 Astellas Pharma Technologies Anticonvulsant Drug Product Portfolios and Specifications
13.2.3 Astellas Pharma Technologies Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Astellas Pharma Technologies Main Business Overview
13.2.5 Astellas Pharma Technologies Latest Developments
13.3 Valeant Pharmaceuticals N.A
13.3.1 Valeant Pharmaceuticals N.A Company Information
13.3.2 Valeant Pharmaceuticals N.A Anticonvulsant Drug Product Portfolios and Specifications
13.3.3 Valeant Pharmaceuticals N.A Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Valeant Pharmaceuticals N.A Main Business Overview
13.3.5 Valeant Pharmaceuticals N.A Latest Developments
13.4 Bausch Health Companies
13.4.1 Bausch Health Companies Company Information
13.4.2 Bausch Health Companies Anticonvulsant Drug Product Portfolios and Specifications
13.4.3 Bausch Health Companies Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bausch Health Companies Main Business Overview
13.4.5 Bausch Health Companies Latest Developments
13.5 Watson Laboratories
13.5.1 Watson Laboratories Company Information
13.5.2 Watson Laboratories Anticonvulsant Drug Product Portfolios and Specifications
13.5.3 Watson Laboratories Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Watson Laboratories Main Business Overview
13.5.5 Watson Laboratories Latest Developments
13.6 Abbott Laboratories
13.6.1 Abbott Laboratories Company Information
13.6.2 Abbott Laboratories Anticonvulsant Drug Product Portfolios and Specifications
13.6.3 Abbott Laboratories Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbott Laboratories Main Business Overview
13.6.5 Abbott Laboratories Latest Developments
13.7 Teva Pharmaceutical Industries
13.7.1 Teva Pharmaceutical Industries Company Information
13.7.2 Teva Pharmaceutical Industries Anticonvulsant Drug Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Teva Pharmaceutical Industries Main Business Overview
13.7.5 Teva Pharmaceutical Industries Latest Developments
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Information
13.8.2 Johnson & Johnson Anticonvulsant Drug Product Portfolios and Specifications
13.8.3 Johnson & Johnson Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Johnson & Johnson Main Business Overview
13.8.5 Johnson & Johnson Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Anticonvulsant Drug Product Portfolios and Specifications
13.9.3 Novartis AG Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Anticonvulsant Drug Product Portfolios and Specifications
13.10.3 Pfizer Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 Shire Plc
13.11.1 Shire Plc Company Information
13.11.2 Shire Plc Anticonvulsant Drug Product Portfolios and Specifications
13.11.3 Shire Plc Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shire Plc Main Business Overview
13.11.5 Shire Plc Latest Developments
13.12 UCB Group
13.12.1 UCB Group Company Information
13.12.2 UCB Group Anticonvulsant Drug Product Portfolios and Specifications
13.12.3 UCB Group Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 UCB Group Main Business Overview
13.12.5 UCB Group Latest Developments
13.13 Huazhong Pharmaceutical Company Limited
13.13.1 Huazhong Pharmaceutical Company Limited Company Information
13.13.2 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Product Portfolios and Specifications
13.13.3 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Huazhong Pharmaceutical Company Limited Main Business Overview
13.13.5 Huazhong Pharmaceutical Company Limited Latest Developments
13.14 Changzhou Siyao Pharmaceutical
13.14.1 Changzhou Siyao Pharmaceutical Company Information
13.14.2 Changzhou Siyao Pharmaceutical Anticonvulsant Drug Product Portfolios and Specifications
13.14.3 Changzhou Siyao Pharmaceutical Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Changzhou Siyao Pharmaceutical Main Business Overview
13.14.5 Changzhou Siyao Pharmaceutical Latest Developments
13.15 Shandong Xinyi Pharmaceutical
13.15.1 Shandong Xinyi Pharmaceutical Company Information
13.15.2 Shandong Xinyi Pharmaceutical Anticonvulsant Drug Product Portfolios and Specifications
13.15.3 Shandong Xinyi Pharmaceutical Anticonvulsant Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shandong Xinyi Pharmaceutical Main Business Overview
13.15.5 Shandong Xinyi Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anticonvulsant Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anticonvulsant Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
Table 4. Major Players of Barbiturate
Table 5. Major Players of Benzodiazepine
Table 6. Major Players of Carbamate Anticonvulsants
Table 7. Major Players of Carbonic Anhydrase Inhibitor
Table 8. Major Players of Dibenzazepine
Table 9. Major Players of Triazine
Table 10. Global Anticonvulsant Drug Sales by Type (2018-2023) & (K Units)
Table 11. Global Anticonvulsant Drug Sales Market Share by Type (2018-2023)
Table 12. Global Anticonvulsant Drug Revenue by Type (2018-2023) & ($ million)
Table 13. Global Anticonvulsant Drug Revenue Market Share by Type (2018-2023)
Table 14. Global Anticonvulsant Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 15. Global Anticonvulsant Drug Sales by Application (2018-2023) & (K Units)
Table 16. Global Anticonvulsant Drug Sales Market Share by Application (2018-2023)
Table 17. Global Anticonvulsant Drug Revenue by Application (2018-2023)
Table 18. Global Anticonvulsant Drug Revenue Market Share by Application (2018-2023)
Table 19. Global Anticonvulsant Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 20. Global Anticonvulsant Drug Sales by Company (2018-2023) & (K Units)
Table 21. Global Anticonvulsant Drug Sales Market Share by Company (2018-2023)
Table 22. Global Anticonvulsant Drug Revenue by Company (2018-2023) ($ Millions)
Table 23. Global Anticonvulsant Drug Revenue Market Share by Company (2018-2023)
Table 24. Global Anticonvulsant Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 25. Key Manufacturers Anticonvulsant Drug Producing Area Distribution and Sales Area
Table 26. Players Anticonvulsant Drug Products Offered
Table 27. Anticonvulsant Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Anticonvulsant Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 31. Global Anticonvulsant Drug Sales Market Share Geographic Region (2018-2023)
Table 32. Global Anticonvulsant Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 33. Global Anticonvulsant Drug Revenue Market Share by Geographic Region (2018-2023)
Table 34. Global Anticonvulsant Drug Sales by Country/Region (2018-2023) & (K Units)
Table 35. Global Anticonvulsant Drug Sales Market Share by Country/Region (2018-2023)
Table 36. Global Anticonvulsant Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 37. Global Anticonvulsant Drug Revenue Market Share by Country/Region (2018-2023)
Table 38. Americas Anticonvulsant Drug Sales by Country (2018-2023) & (K Units)
Table 39. Americas Anticonvulsant Drug Sales Market Share by Country (2018-2023)
Table 40. Americas Anticonvulsant Drug Revenue by Country (2018-2023) & ($ Millions)
Table 41. Americas Anticonvulsant Drug Revenue Market Share by Country (2018-2023)
Table 42. Americas Anticonvulsant Drug Sales by Type (2018-2023) & (K Units)
Table 43. Americas Anticonvulsant Drug Sales by Application (2018-2023) & (K Units)
Table 44. APAC Anticonvulsant Drug Sales by Region (2018-2023) & (K Units)
Table 45. APAC Anticonvulsant Drug Sales Market Share by Region (2018-2023)
Table 46. APAC Anticonvulsant Drug Revenue by Region (2018-2023) & ($ Millions)
Table 47. APAC Anticonvulsant Drug Revenue Market Share by Region (2018-2023)
Table 48. APAC Anticonvulsant Drug Sales by Type (2018-2023) & (K Units)
Table 49. APAC Anticonvulsant Drug Sales by Application (2018-2023) & (K Units)
Table 50. Europe Anticonvulsant Drug Sales by Country (2018-2023) & (K Units)
Table 51. Europe Anticonvulsant Drug Sales Market Share by Country (2018-2023)
Table 52. Europe Anticonvulsant Drug Revenue by Country (2018-2023) & ($ Millions)
Table 53. Europe Anticonvulsant Drug Revenue Market Share by Country (2018-2023)
Table 54. Europe Anticonvulsant Drug Sales by Type (2018-2023) & (K Units)
Table 55. Europe Anticonvulsant Drug Sales by Application (2018-2023) & (K Units)
Table 56. Middle East & Africa Anticonvulsant Drug Sales by Country (2018-2023) & (K Units)
Table 57. Middle East & Africa Anticonvulsant Drug Sales Market Share by Country (2018-2023)
Table 58. Middle East & Africa Anticonvulsant Drug Revenue by Country (2018-2023) & ($ Millions)
Table 59. Middle East & Africa Anticonvulsant Drug Revenue Market Share by Country (2018-2023)
Table 60. Middle East & Africa Anticonvulsant Drug Sales by Type (2018-2023) & (K Units)
Table 61. Middle East & Africa Anticonvulsant Drug Sales by Application (2018-2023) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Anticonvulsant Drug
Table 63. Key Market Challenges & Risks of Anticonvulsant Drug
Table 64. Key Industry Trends of Anticonvulsant Drug
Table 65. Anticonvulsant Drug Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Anticonvulsant Drug Distributors List
Table 68. Anticonvulsant Drug Customer List
Table 69. Global Anticonvulsant Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 70. Global Anticonvulsant Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Americas Anticonvulsant Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Americas Anticonvulsant Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. APAC Anticonvulsant Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 74. APAC Anticonvulsant Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 75. Europe Anticonvulsant Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Europe Anticonvulsant Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Middle East & Africa Anticonvulsant Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 78. Middle East & Africa Anticonvulsant Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 79. Global Anticonvulsant Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 80. Global Anticonvulsant Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 81. Global Anticonvulsant Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 82. Global Anticonvulsant Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 83. GlaxoSmithKline Plc Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Plc Anticonvulsant Drug Product Portfolios and Specifications
Table 85. GlaxoSmithKline Plc Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Plc Main Business
Table 87. GlaxoSmithKline Plc Latest Developments
Table 88. Astellas Pharma Technologies Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Astellas Pharma Technologies Anticonvulsant Drug Product Portfolios and Specifications
Table 90. Astellas Pharma Technologies Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Astellas Pharma Technologies Main Business
Table 92. Astellas Pharma Technologies Latest Developments
Table 93. Valeant Pharmaceuticals N.A Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Valeant Pharmaceuticals N.A Anticonvulsant Drug Product Portfolios and Specifications
Table 95. Valeant Pharmaceuticals N.A Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Valeant Pharmaceuticals N.A Main Business
Table 97. Valeant Pharmaceuticals N.A Latest Developments
Table 98. Bausch Health Companies Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Bausch Health Companies Anticonvulsant Drug Product Portfolios and Specifications
Table 100. Bausch Health Companies Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Bausch Health Companies Main Business
Table 102. Bausch Health Companies Latest Developments
Table 103. Watson Laboratories Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Watson Laboratories Anticonvulsant Drug Product Portfolios and Specifications
Table 105. Watson Laboratories Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Watson Laboratories Main Business
Table 107. Watson Laboratories Latest Developments
Table 108. Abbott Laboratories Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Laboratories Anticonvulsant Drug Product Portfolios and Specifications
Table 110. Abbott Laboratories Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Abbott Laboratories Main Business
Table 112. Abbott Laboratories Latest Developments
Table 113. Teva Pharmaceutical Industries Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Industries Anticonvulsant Drug Product Portfolios and Specifications
Table 115. Teva Pharmaceutical Industries Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Teva Pharmaceutical Industries Main Business
Table 117. Teva Pharmaceutical Industries Latest Developments
Table 118. Johnson & Johnson Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson & Johnson Anticonvulsant Drug Product Portfolios and Specifications
Table 120. Johnson & Johnson Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Johnson & Johnson Main Business
Table 122. Johnson & Johnson Latest Developments
Table 123. Novartis AG Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Novartis AG Anticonvulsant Drug Product Portfolios and Specifications
Table 125. Novartis AG Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Novartis AG Main Business
Table 127. Novartis AG Latest Developments
Table 128. Pfizer Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Pfizer Anticonvulsant Drug Product Portfolios and Specifications
Table 130. Pfizer Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Pfizer Main Business
Table 132. Pfizer Latest Developments
Table 133. Shire Plc Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Shire Plc Anticonvulsant Drug Product Portfolios and Specifications
Table 135. Shire Plc Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Shire Plc Main Business
Table 137. Shire Plc Latest Developments
Table 138. UCB Group Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. UCB Group Anticonvulsant Drug Product Portfolios and Specifications
Table 140. UCB Group Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. UCB Group Main Business
Table 142. UCB Group Latest Developments
Table 143. Huazhong Pharmaceutical Company Limited Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Product Portfolios and Specifications
Table 145. Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Huazhong Pharmaceutical Company Limited Main Business
Table 147. Huazhong Pharmaceutical Company Limited Latest Developments
Table 148. Changzhou Siyao Pharmaceutical Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. Changzhou Siyao Pharmaceutical Anticonvulsant Drug Product Portfolios and Specifications
Table 150. Changzhou Siyao Pharmaceutical Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Changzhou Siyao Pharmaceutical Main Business
Table 152. Changzhou Siyao Pharmaceutical Latest Developments
Table 153. Shandong Xinyi Pharmaceutical Basic Information, Anticonvulsant Drug Manufacturing Base, Sales Area and Its Competitors
Table 154. Shandong Xinyi Pharmaceutical Anticonvulsant Drug Product Portfolios and Specifications
Table 155. Shandong Xinyi Pharmaceutical Anticonvulsant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Shandong Xinyi Pharmaceutical Main Business
Table 157. Shandong Xinyi Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Anticonvulsant Drug
Figure 2. Anticonvulsant Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anticonvulsant Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anticonvulsant Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anticonvulsant Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
Figure 10. Product Picture of Barbiturate
Figure 11. Product Picture of Benzodiazepine
Figure 12. Product Picture of Carbamate Anticonvulsants
Figure 13. Product Picture of Carbonic Anhydrase Inhibitor
Figure 14. Product Picture of Dibenzazepine
Figure 15. Product Picture of Triazine
Figure 16. Global Anticonvulsant Drug Sales Market Share by Type in 2022
Figure 17. Global Anticonvulsant Drug Revenue Market Share by Type (2018-2023)
Figure 18. Anticonvulsant Drug Consumed in Anxiety
Figure 19. Global Anticonvulsant Drug Market: Anxiety (2018-2023) & (K Units)
Figure 20. Anticonvulsant Drug Consumed in Bipolar Disorder
Figure 21. Global Anticonvulsant Drug Market: Bipolar Disorder (2018-2023) & (K Units)
Figure 22. Anticonvulsant Drug Consumed in Borderline Personality Disorder
Figure 23. Global Anticonvulsant Drug Market: Borderline Personality Disorder (2018-2023) & (K Units)
Figure 24. Anticonvulsant Drug Consumed in Epilepsy
Figure 25. Global Anticonvulsant Drug Market: Epilepsy (2018-2023) & (K Units)
Figure 26. Anticonvulsant Drug Consumed in Fibromyalgia
Figure 27. Global Anticonvulsant Drug Market: Fibromyalgia (2018-2023) & (K Units)
Figure 28. Anticonvulsant Drug Consumed in Migraine
Figure 29. Global Anticonvulsant Drug Market: Migraine (2018-2023) & (K Units)
Figure 30. Anticonvulsant Drug Consumed in Neuropathic Pain
Figure 31. Global Anticonvulsant Drug Market: Neuropathic Pain (2018-2023) & (K Units)
Figure 32. Anticonvulsant Drug Consumed in Others
Figure 33. Global Anticonvulsant Drug Market: Others (2018-2023) & (K Units)
Figure 34. Global Anticonvulsant Drug Sales Market Share by Application (2022)
Figure 35. Global Anticonvulsant Drug Revenue Market Share by Application in 2022
Figure 36. Anticonvulsant Drug Sales Market by Company in 2022 (K Units)
Figure 37. Global Anticonvulsant Drug Sales Market Share by Company in 2022
Figure 38. Anticonvulsant Drug Revenue Market by Company in 2022 ($ Million)
Figure 39. Global Anticonvulsant Drug Revenue Market Share by Company in 2022
Figure 40. Global Anticonvulsant Drug Sales Market Share by Geographic Region (2018-2023)
Figure 41. Global Anticonvulsant Drug Revenue Market Share by Geographic Region in 2022
Figure 42. Americas Anticonvulsant Drug Sales 2018-2023 (K Units)
Figure 43. Americas Anticonvulsant Drug Revenue 2018-2023 ($ Millions)
Figure 44. APAC Anticonvulsant Drug Sales 2018-2023 (K Units)
Figure 45. APAC Anticonvulsant Drug Revenue 2018-2023 ($ Millions)
Figure 46. Europe Anticonvulsant Drug Sales 2018-2023 (K Units)
Figure 47. Europe Anticonvulsant Drug Revenue 2018-2023 ($ Millions)
Figure 48. Middle East & Africa Anticonvulsant Drug Sales 2018-2023 (K Units)
Figure 49. Middle East & Africa Anticonvulsant Drug Revenue 2018-2023 ($ Millions)
Figure 50. Americas Anticonvulsant Drug Sales Market Share by Country in 2022
Figure 51. Americas Anticonvulsant Drug Revenue Market Share by Country in 2022
Figure 52. Americas Anticonvulsant Drug Sales Market Share by Type (2018-2023)
Figure 53. Americas Anticonvulsant Drug Sales Market Share by Application (2018-2023)
Figure 54. United States Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. Canada Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Mexico Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. Brazil Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. APAC Anticonvulsant Drug Sales Market Share by Region in 2022
Figure 59. APAC Anticonvulsant Drug Revenue Market Share by Regions in 2022
Figure 60. APAC Anticonvulsant Drug Sales Market Share by Type (2018-2023)
Figure 61. APAC Anticonvulsant Drug Sales Market Share by Application (2018-2023)
Figure 62. China Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. Japan Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. South Korea Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Southeast Asia Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. India Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Australia Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. China Taiwan Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Europe Anticonvulsant Drug Sales Market Share by Country in 2022
Figure 70. Europe Anticonvulsant Drug Revenue Market Share by Country in 2022
Figure 71. Europe Anticonvulsant Drug Sales Market Share by Type (2018-2023)
Figure 72. Europe Anticonvulsant Drug Sales Market Share by Application (2018-2023)
Figure 73. Germany Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. France Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. UK Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. Italy Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 77. Russia Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 78. Middle East & Africa Anticonvulsant Drug Sales Market Share by Country in 2022
Figure 79. Middle East & Africa Anticonvulsant Drug Revenue Market Share by Country in 2022
Figure 80. Middle East & Africa Anticonvulsant Drug Sales Market Share by Type (2018-2023)
Figure 81. Middle East & Africa Anticonvulsant Drug Sales Market Share by Application (2018-2023)
Figure 82. Egypt Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 83. South Africa Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 84. Israel Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 85. Turkey Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 86. GCC Country Anticonvulsant Drug Revenue Growth 2018-2023 ($ Millions)
Figure 87. Manufacturing Cost Structure Analysis of Anticonvulsant Drug in 2022
Figure 88. Manufacturing Process Analysis of Anticonvulsant Drug
Figure 89. Industry Chain Structure of Anticonvulsant Drug
Figure 90. Channels of Distribution
Figure 91. Global Anticonvulsant Drug Sales Market Forecast by Region (2024-2029)
Figure 92. Global Anticonvulsant Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 93. Global Anticonvulsant Drug Sales Market Share Forecast by Type (2024-2029)
Figure 94. Global Anticonvulsant Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 95. Global Anticonvulsant Drug Sales Market Share Forecast by Application (2024-2029)
Figure 96. Global Anticonvulsant Drug Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の抗けいれん薬市場予測 2023年-2029年] (コード：LP23DC02887)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗けいれん薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアシクロビル治療薬市場予測 2023年-2029年
  • 世界のPD-1抗体薬市場予測 2023年-2029年
  • 世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年
  • 世界の抗早漏薬市場予測 2023年-2029年
  • 世界の自動薬剤感受性解析装置市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆